Follow-up examination after treatment for conditions other than malignant neoplasms

MESH PheWeb

No definition available.

Endpoint definition

↥

FinnGen phenotype data

Filter registries Inpat., Oupat., Death

Hospital Discharge: ICD-10 Z09

Cause of death: ICD-10 Z09

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

Z21_FOLLOW__EXAM_TREAT_CONDI_OTH_MALIG_NEOPLASMS

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF4

Parent code in ICD-10 Z[0-1]

Similar endpoints

↥

List of similar endpoints to Follow-up examination after treatment for conditions other than malignant neoplasms based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	15329	12550	2779
Unadjusted prevalence (%)	5.90	8.54	2.46
Mean age at first event (years)	49.21	48.13	54.06

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.03	1.95 [1.48, 2.56]	1.6e-6	744
15 years	0.02	2.34 [1.88, 2.90]	1.2e-14	661
5 years	0.00	3.32 [2.68, 4.11]	2.3e-28	261
1 year	0.00	4.54 [3.35, 6.16]	2.5e-22	64

Correlations

↥

Index endpoint: Z21_FOLLOW__EXAM_TREAT_CONDI_OTH_MALIG_NEOPLASMS – Follow-up examination after treatment for conditions other than malignant neoplasms
GWS hits: 0

Survival analyses between endpoints

↥

Plot

before Follow-up examination after treatment for conditions other than malignant neoplasms
after Follow-up examination after treatment for conditions other than malignant neoplasms

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Follow-up examination after treatment for conditions other than malignant neoplasms

↥